{
    "startDate": "2020-01-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 215432713
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 156231102
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 3513159
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 482373
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 4591966
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 1811140
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 382062453
            },
            {
                "label": "Fixed Assets, net of accumulated depreciation",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 11323531
            },
            {
                "label": "Investment in affiliated entities",
                "concept": "EquitySecuritiesFvNi",
                "unit": "usd",
                "value": 17327569
            },
            {
                "label": "Schedule of Equity Method Investments",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 2717241
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3420311
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 13265144
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2555782
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 443185402
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 17216875
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 511953
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:AccruedClinicalTrialExpenseCurrent",
                "unit": "usd",
                "value": 6870450
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 14853
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:ContractWithCustomerLiabilityAffiliatedEntityCurrent",
                "unit": "usd",
                "value": 94275
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2200459
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:DeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 10330235
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:DeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": 742875
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 37981975
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 86641
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilities",
                "unit": "usd",
                "value": 119796000
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 19261354
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 32046
            },
            {
                "label": "Grant funding liability from affiliated entity, net of current portion",
                "concept": "ino:DeferredGrantFundingFromAffiliateNoncurrent",
                "unit": "usd",
                "value": 37500
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 66629
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 256824933
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 158756
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 1087745242
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -901029768
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -610030
            },
            {
                "label": "Stockholders' Equity Note [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 186264200
            },
            {
                "label": "Noncontrolling Interest [Table]",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 96269
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 186360469
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 443185402
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -162307870
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1608060
            },
            {
                "label": "Aggregate amortization expense on intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 273540
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": 110976977
            },
            {
                "label": "Number of shares authorized (in shares)",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 7663988
            },
            {
                "label": "Non-cash interest expense",
                "concept": "ino:NonCashInterestExpense",
                "unit": "usd",
                "value": 3013942
            },
            {
                "label": "Amortization of premiums on investments",
                "concept": "ino:InterestIncomeAccruedOnShortTermInvestmentsCertificatesOfDeposit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss on short-term investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": -576001
            },
            {
                "label": "Settlement of receivable with shares of common stock from affiliated entity (PLS)",
                "concept": "ino:SettlementOfReceivableWithSharesOfCommonStockFromEquitySecurity",
                "unit": "usd",
                "value": 1713770
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "(Gain) loss on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 9298443
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -901757
            },
            {
                "label": "Net unrealized loss on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedLoss",
                "unit": "usd",
                "value": 691458
            },
            {
                "label": "Non-cash lease expense",
                "concept": "ino:OperatingLeaseNonCashLeaseExpense",
                "unit": "usd",
                "value": 517865
            },
            {
                "label": "Tax benefit from other unrealized gains on short-term investments",
                "concept": "ino:TaxBenefitFromUnrealizedGainsLossesOnShortTermInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Unrealized transaction loss on foreign-currency denominated debt",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 474071
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 2813086
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": -865832
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 3084082
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 1330601
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -116242
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -732774
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:IncreaseDecreaseInAccruedClinicalTrialExpense",
                "unit": "usd",
                "value": 2882486
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": 4634
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -92426
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": 62500
            },
            {
                "label": "Operating lease right-of-use assets and liabilities, net",
                "concept": "ino:IncreaseDecreaseInOperatingLeaseRightOfUseAssetLeaseLiabilityNet",
                "unit": "usd",
                "value": -1022951
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 4265023
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": -63050
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 29686
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -52604208
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 138698249
            },
            {
                "label": "Proceeds from sale or maturity of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 47455067
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 176534
            },
            {
                "label": "Decrease in cash resulting from the deconsolidation of Geneos",
                "concept": "CashDivestedFromDeconsolidation",
                "unit": "usd",
                "value": 2774851
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -94194567
            },
            {
                "label": "Proceeds from issuance of convertible senior notes",
                "concept": "ProceedsFromIssuanceOfLongTermDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 329960855
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 9599514
            },
            {
                "label": "Taxes paid related to net share settlement of equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 2076567
            },
            {
                "label": "Acquisition of non-controlling interest",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": 2379969
            },
            {
                "label": "Proceeds from Geneos issuance of note payable",
                "concept": "ProceedsFromNotesPayable",
                "unit": "usd",
                "value": 171620
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 340035391
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Increase (Decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 193236616
            },
            {
                "label": "Amounts accrued for purchases of property and equipment",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 1620
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 2636454
            },
            {
                "label": "Right-of-use assets obtained in exchange for lease obligations",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -162307870
            },
            {
                "label": "Unrealized gain (loss) on short-term investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -1082638
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -163390508
            },
            {
                "label": "Comprehensive loss attributable to non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1063757
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -162326751
            },
            {
                "label": "Revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1594461
            },
            {
                "label": "Research and Development Expense",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 41487763
            },
            {
                "label": "General and Administrative Expense",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 18519864
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 60007627
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -58413166
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 1483968
            },
            {
                "label": "Non-cash interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 5650396
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
                "unit": "usd",
                "value": -110976977
            },
            {
                "label": "(Gain) loss on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": 9298443
            },
            {
                "label": "Net unrealized gain (loss) on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": -691458
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -577602
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": 4121075
            },
            {
                "label": "Net loss before income tax benefit and share in net loss of Geneos",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -161406113
            },
            {
                "label": "Income tax benefit",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -901757
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1063757
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -161244113
            },
            {
                "label": "Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -1.15
            },
            {
                "label": "Basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 140215158
            }
        ]
    }
}